PL339493A1 - Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitors - Google Patents
Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitorsInfo
- Publication number
- PL339493A1 PL339493A1 PL98339493A PL33949398A PL339493A1 PL 339493 A1 PL339493 A1 PL 339493A1 PL 98339493 A PL98339493 A PL 98339493A PL 33949398 A PL33949398 A PL 33949398A PL 339493 A1 PL339493 A1 PL 339493A1
- Authority
- PL
- Poland
- Prior art keywords
- thinaphtalen
- phospholamane
- aza
- oxa
- ethers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL339493A1 true PL339493A1 (en) | 2000-12-18 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98339493A PL339493A1 (en) | 1997-09-24 | 1998-09-24 | Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (en) |
| JP (1) | JP2003525838A (en) |
| KR (1) | KR20010015607A (en) |
| CN (1) | CN1143857C (en) |
| AU (1) | AU735729B2 (en) |
| BR (1) | BR9813216A (en) |
| CA (1) | CA2304849A1 (en) |
| EA (1) | EA003084B1 (en) |
| EE (1) | EE04494B1 (en) |
| HU (1) | HUP0003647A3 (en) |
| ID (1) | ID24373A (en) |
| IL (1) | IL134662A0 (en) |
| NO (1) | NO20001569D0 (en) |
| NZ (1) | NZ503044A (en) |
| PL (1) | PL339493A1 (en) |
| SK (1) | SK3902000A3 (en) |
| TR (1) | TR200000764T2 (en) |
| WO (1) | WO1999015523A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4890723B2 (en) * | 2000-07-21 | 2012-03-07 | 中外製薬株式会社 | Coumarin derivatives useful as TNFα inhibitors |
| JP2004528319A (en) * | 2001-03-30 | 2004-09-16 | ファイザー・プロダクツ・インク | Pyridazinone aldose reductase inhibitor |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (en) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | NOVEL AZACOUMARIN DERIVATIVES WITH INHIBITOR ACTIVITY OF MDR PUMPS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (en) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | Coronary dilator 2-benzopyranones, active by enteral admin. - contg. trimethoxybenzoyl or trimethoxycinnamoyl substits. |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| DE68920797T2 (en) * | 1988-08-10 | 1995-06-29 | Otsuka Pharma Co Ltd | Heart medication. |
| IE902750A1 (en) * | 1989-07-31 | 1991-02-27 | Sankyo Co | Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders |
| DE4337906A1 (en) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Use of coumarin derivatives |
-
1998
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/en unknown
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/en not_active Application Discontinuation
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/en unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/en unknown
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/en active Pending
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/en not_active Application Discontinuation
- 1998-09-24 ID IDW20000564A patent/ID24373A/en unknown
- 1998-09-24 EP EP98946482A patent/EP1017691A1/en not_active Withdrawn
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/en not_active Expired - Fee Related
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 CA CA002304849A patent/CA2304849A1/en not_active Abandoned
- 1998-09-24 EA EA200000352A patent/EA003084B1/en not_active IP Right Cessation
- 1998-09-24 EE EEP200000179A patent/EE04494B1/en not_active IP Right Cessation
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/en not_active IP Right Cessation
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/en unknown
- 1998-09-24 PL PL98339493A patent/PL339493A1/en unknown
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200000352A1 (en) | 2000-10-30 |
| SK3902000A3 (en) | 2000-12-11 |
| EE04494B1 (en) | 2005-06-15 |
| HUP0003647A2 (en) | 2001-08-28 |
| NO20001569L (en) | 2000-03-24 |
| KR20010015607A (en) | 2001-02-26 |
| CN1271357A (en) | 2000-10-25 |
| EP1017691A1 (en) | 2000-07-12 |
| AU9350898A (en) | 1999-04-12 |
| AU735729B2 (en) | 2001-07-12 |
| CN1143857C (en) | 2004-03-31 |
| TR200000764T2 (en) | 2001-03-21 |
| HUP0003647A3 (en) | 2002-12-28 |
| EE200000179A (en) | 2001-04-16 |
| BR9813216A (en) | 2000-08-29 |
| WO1999015523A1 (en) | 1999-04-01 |
| NO20001569D0 (en) | 2000-03-24 |
| CA2304849A1 (en) | 1999-04-01 |
| JP2003525838A (en) | 2003-09-02 |
| NZ503044A (en) | 2001-08-31 |
| IL134662A0 (en) | 2001-04-30 |
| EA003084B1 (en) | 2002-12-26 |
| ID24373A (en) | 2000-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
| ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
| HK1044545A1 (en) | Human beta-secretase enzyme, inhibitors and their compositions and uses | |
| HUP9800634A3 (en) | P-amidino-benzylamide derivatives as thrombin inhibitors, intermediates and use thereof | |
| PL337645A1 (en) | Novel amidine derivatives and their application as thrombosin inhibitors | |
| HK1008995A1 (en) | New thrombin inhibitors, their preparation and use | |
| PL331047A1 (en) | Novel amidinic derivatives and their application as inhibitors of thrombosin | |
| ZA9811649B (en) | Absorbent article and method of wrapping. | |
| ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
| HU0900792D0 (en) | Use of renin-angiotensin inhibitors | |
| AU5463099A (en) | Inhibitors of redox signaling and methods of using same | |
| GB2346823B (en) | Reamer and method of using the same | |
| HUP9904165A3 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase and use thereof | |
| HK1048318B (en) | Substituted 3-phenyl-5-alkoxi-1, 3,4-oxdiazol-2-ones and their use as lipase inhibitors | |
| GB9725114D0 (en) | Treatment of pruritus | |
| ZA200006020B (en) | Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. | |
| ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin | |
| HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
| PL339493A1 (en) | Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitors | |
| GB9814269D0 (en) | 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment | |
| GB9713139D0 (en) | Use of enzymes | |
| PL338862A1 (en) | Derivatives of 2-oxypyroimidin-4-one and 2-oxypyroimidin-4-thione | |
| SI1214302T1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |